Back
30
Day Range
$6.43
$6.63
52-Week Range
$3.74
$8.09
Volume
1,642,016
50D / 200D Avg
$7.01
/
$5.87
Prev Close
$6.40
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 263.4 | 0.4 |
| P/B | 1.7 | 2.9 |
| ROE % | 0.7 | 3.8 |
| Net Margin % | 0.7 | 3.9 |
| Rev Growth 5Y % | 20.9 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$9.30
+42.4%
Low: $8.00
High: $11.00
Forward P/E
89.3
Forward EPS
$0.07
EPS Growth (est.)
+0.0%
Est. Revenue
1.6 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$0.33
$0.22 – $0.40
|
2.1 B | 4 |
| FY2027 |
$0.14
$0.13 – $0.15
|
1.9 B | 4 |
| FY2026 |
$0.07
$0.06 – $0.08
|
1.6 B | 4 |
Key Takeaways
Revenue grew 20.86% annually over 5 years — strong growth
ROE of 0.65% is below average
Debt/Equity of 0.13 — conservative balance sheet
Generating 110.03M in free cash flow
P/E of 263.41 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 7.01%
Growth
Revenue Growth (5Y)
20.86%
Revenue (1Y)13.85%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
0.65%
ROIC1.12%
Net Margin0.68%
Op. Margin1.80%
Safety
Debt / Equity
0.13
Current Ratio1.65
Interest Coverage2.20
Valuation
P/E Ratio
263.41
P/B Ratio1.67
EV/EBITDA96.89
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13.85% | Revenue Growth (3Y) | 16.15% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 20.86% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.42B | Net Income (TTM) | 9.66M |
| ROE | 0.65% | ROA | 0.44% |
| Gross Margin | 28.53% | Operating Margin | 1.80% |
| Net Margin | 0.68% | Free Cash Flow (TTM) | 110.03M |
| ROIC | 1.12% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.13 | Current Ratio | 1.65 |
| Interest Coverage | 2.20 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 263.41 | P/B Ratio | 1.67 |
| P/S Ratio | 1.79 | PEG Ratio | -2.34 |
| EV/EBITDA | 96.89 | Dividend Yield | 0.00% |
| Market Cap | 2.55B | Enterprise Value | 2.49B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.42B | 1.25B | 1.06B | 859.54M | 667.51M |
| Net Income | 9.66M | -57.44M | -186.26M | -215.56M | -307.20M |
| EPS (Diluted) | 0.02 | -0.15 | -0.51 | -0.61 | -1.05 |
| Gross Profit | 406.35M | 402.40M | 302.10M | 237.02M | 201.51M |
| Operating Income | 25.71M | -31.61M | -189.13M | -210.17M | -286.35M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.20B | 2.12B | 2.11B | 2.17B | 1.93B |
| Total Liabilities | 682.92M | 672.01M | 681.04M | 655.15M | 382.08M |
| Shareholders' Equity | 1.52B | 1.45B | 1.43B | 1.52B | 1.55B |
| Total Debt | 194.10M | 485.19M | 511.04M | 478.83M | 158.74M |
| Cash & Equivalents | 248.64M | 154.57M | 78.82M | 108.62M | 148.03M |
| Current Assets | 416.20M | 312.51M | 225.73M | 233.22M | 266.52M |
| Current Liabilities | 251.96M | 228.89M | 202.87M | 176.00M | 116.75M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#809 of 1024
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026